Disc Medicine, Inc. (IRON)
NASDAQ: IRON · IEX Real-Time Price · USD
27.55
+1.03 (3.88%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Disc Medicine Employees
Disc Medicine had 74 employees on December 31, 2023. The number of employees increased by 28 or 60.87% compared to the previous year.
Employees
74
Change (1Y)
28
Growth (1Y)
60.87%
Revenue / Employee
n/a
Profits / Employee
-$1,032,824
Market Cap
679.96M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 74 | 28 | 60.87% |
Dec 31, 2022 | 46 | 13 | 39.39% |
Dec 31, 2021 | 33 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
IRON News
- 25 days ago - Top 3 Health Care Stocks You'll Regret Missing This Month - Humana (NYSE:HUM), Disc Medicine (NASDAQ:IRON) - Benzinga
- 26 days ago - Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) - GlobeNewsWire
- 5 weeks ago - Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024 - GlobeNewsWire
- 2 months ago - Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - FDA Grants Orphan Drug Designation to 9MW3011 - PRNewsWire
- 2 months ago - Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease - GlobeNewsWire
- 2 months ago - Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera - GlobeNewsWire